Wintrust Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$691K Sell
3,891
-628
-14% -$112K 0.61% 32
2024
Q3
$892K Sell
4,519
-39,207
-90% -$7.74M 0.66% 28
2024
Q2
$7.5M Buy
43,726
+937
+2% +$161K 0.61% 31
2024
Q1
$7.79M Buy
42,789
+19
+0% +$3.46K 0.69% 28
2023
Q4
$6.63M Buy
42,770
+2,706
+7% +$419K 0.64% 29
2023
Q3
$5.97M Buy
40,064
+2,924
+8% +$436K 0.63% 34
2023
Q2
$5M Buy
37,140
+10,493
+39% +$1.41M 0.5% 40
2023
Q1
$4.25M Buy
26,647
+831
+3% +$132K 0.54% 36
2022
Q4
$4.17M Sell
25,816
-251
-1% -$40.6K 0.55% 37
2022
Q3
$3.5M Buy
26,067
+431
+2% +$57.8K 0.44% 45
2022
Q2
$3.93M Buy
25,636
+1,421
+6% +$218K 0.47% 42
2022
Q1
$3.93M Sell
24,215
-873
-3% -$142K 0.38% 46
2021
Q4
$3.4M Sell
25,088
-585
-2% -$79.2K 0.32% 50
2021
Q3
$2.77M Sell
25,673
-440
-2% -$47.5K 0.37% 52
2021
Q2
$2.94M Buy
26,113
+339
+1% +$38.2K 0.3% 62
2021
Q1
$2.79M Sell
25,774
-127
-0.5% -$13.7K 0.29% 70
2020
Q4
$2.78M Buy
25,901
+563
+2% +$60.3K 0.79% 31
2020
Q3
$2.22M Buy
25,338
+999
+4% +$87.5K 0.3% 70
2020
Q2
$2.39M Buy
24,339
+1,543
+7% +$152K 0.33% 58
2020
Q1
$1.74M Buy
22,796
+975
+4% +$74.3K 0.29% 67
2019
Q4
$1.93M Sell
21,821
-754
-3% -$66.8K 0.27% 73
2019
Q3
$1.75M Sell
22,575
-11,109
-33% -$859K 0.26% 71
2019
Q2
$2.78M Sell
33,684
-4,717
-12% -$390K 0.42% 49
2019
Q1
$3.46M Buy
38,401
+18,131
+89% +$1.63M 0.56% 34
2018
Q4
$1.96M Buy
20,270
+6,989
+53% +$675K 0.37% 56
2018
Q3
$1.26M Sell
13,281
-2,371
-15% -$224K 0.2% 97
2018
Q2
$1.45M Buy
15,652
+2,217
+17% +$205K 0.25% 86
2018
Q1
$1.27M Sell
13,435
-15,147
-53% -$1.43M 0.32% 62
2017
Q4
$2.76M Buy
28,582
+382
+1% +$36.9K 0.65% 28
2017
Q3
$2.51M Sell
28,200
-1,328
-4% -$118K 0.63% 27
2017
Q2
$2.14M Buy
29,528
+235
+0.8% +$17K 0.57% 34
2017
Q1
$1.91M Buy
29,293
+18,544
+173% +$1.21M 0.54% 30
2016
Q4
$673K Buy
10,749
+1,597
+17% +$100K 0.28% 71
2016
Q3
$577K Sell
9,152
-3,825
-29% -$241K 0.27% 76
2016
Q2
$3K Buy
+12,977
New +$3K 0.01% 176